Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More | Alex Lash | 06/28/19 | National |
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M | Sarah de Crescenzo | 02/06/19 | San Diego |
For San Antonio’s Consideration: A Biotech Incubator and Accelerator | David Holley | 04/08/16 | Texas |
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline | Ryan McBride | 01/25/10 | Boston |